Cargando…
IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis
Inflammatory signaling is thought to modulate the neurodegenerative cascade in amyotrophic lateral sclerosis (ALS). We have previously shown that expression of Interleukin-10 (IL-10), a classical anti-inflammatory cytokine, extends lifespan in the SOD1-G93A mouse model of familial ALS. Here we test...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705692/ https://www.ncbi.nlm.nih.gov/pubmed/33257786 http://dx.doi.org/10.1038/s41598-020-77564-3 |
_version_ | 1783616996360847360 |
---|---|
author | Strickland, Michael R. Ibanez, Kristen R. Yaroshenko, Mariya Diaz, Carolina Ceballos Borchelt, David R. Chakrabarty, Paramita |
author_facet | Strickland, Michael R. Ibanez, Kristen R. Yaroshenko, Mariya Diaz, Carolina Ceballos Borchelt, David R. Chakrabarty, Paramita |
author_sort | Strickland, Michael R. |
collection | PubMed |
description | Inflammatory signaling is thought to modulate the neurodegenerative cascade in amyotrophic lateral sclerosis (ALS). We have previously shown that expression of Interleukin-10 (IL-10), a classical anti-inflammatory cytokine, extends lifespan in the SOD1-G93A mouse model of familial ALS. Here we test whether co-expression of the decoy chemokine receptor M3, that can scavenge inflammatory chemokines, augments the efficacy of IL-10. We found that recombinant adeno-associated virus (AAV)-mediated expression of IL-10, alone, or in combination with M3, resulted in modest extension of lifespan relative to control SOD1-G93A cohort. Interestingly neither AAV-M3 alone nor AAV-IL-10 + AAV-M3 extend survival beyond that of the AAV-IL-10 alone cohort. Focused transcriptomic analysis revealed induction of innate immunity and phagocytotic pathways in presymptomatic SOD1-G93A mice expressing IL-10 + M3 or IL-10 alone. Further, while IL-10 expression increased microglial burden, the IL-10 + M3 group showed lower microglial burden, suggesting that M3 can successfully lower microgliosis before disease onset. Our data demonstrates that over-expression of an anti-inflammatory cytokine and a decoy chemokine receptor can modulate inflammatory processes in SOD1-G93A mice, modestly delaying the age to paralysis. This suggests that multiple inflammatory pathways can be targeted simultaneously in neurodegenerative disease and supports consideration of adapting these approaches to treatment of ALS and related disorders. |
format | Online Article Text |
id | pubmed-7705692 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-77056922020-12-02 IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis Strickland, Michael R. Ibanez, Kristen R. Yaroshenko, Mariya Diaz, Carolina Ceballos Borchelt, David R. Chakrabarty, Paramita Sci Rep Article Inflammatory signaling is thought to modulate the neurodegenerative cascade in amyotrophic lateral sclerosis (ALS). We have previously shown that expression of Interleukin-10 (IL-10), a classical anti-inflammatory cytokine, extends lifespan in the SOD1-G93A mouse model of familial ALS. Here we test whether co-expression of the decoy chemokine receptor M3, that can scavenge inflammatory chemokines, augments the efficacy of IL-10. We found that recombinant adeno-associated virus (AAV)-mediated expression of IL-10, alone, or in combination with M3, resulted in modest extension of lifespan relative to control SOD1-G93A cohort. Interestingly neither AAV-M3 alone nor AAV-IL-10 + AAV-M3 extend survival beyond that of the AAV-IL-10 alone cohort. Focused transcriptomic analysis revealed induction of innate immunity and phagocytotic pathways in presymptomatic SOD1-G93A mice expressing IL-10 + M3 or IL-10 alone. Further, while IL-10 expression increased microglial burden, the IL-10 + M3 group showed lower microglial burden, suggesting that M3 can successfully lower microgliosis before disease onset. Our data demonstrates that over-expression of an anti-inflammatory cytokine and a decoy chemokine receptor can modulate inflammatory processes in SOD1-G93A mice, modestly delaying the age to paralysis. This suggests that multiple inflammatory pathways can be targeted simultaneously in neurodegenerative disease and supports consideration of adapting these approaches to treatment of ALS and related disorders. Nature Publishing Group UK 2020-11-30 /pmc/articles/PMC7705692/ /pubmed/33257786 http://dx.doi.org/10.1038/s41598-020-77564-3 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Strickland, Michael R. Ibanez, Kristen R. Yaroshenko, Mariya Diaz, Carolina Ceballos Borchelt, David R. Chakrabarty, Paramita IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis |
title | IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis |
title_full | IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis |
title_fullStr | IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis |
title_full_unstemmed | IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis |
title_short | IL-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis |
title_sort | il-10 based immunomodulation initiated at birth extends lifespan in a familial mouse model of amyotrophic lateral sclerosis |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7705692/ https://www.ncbi.nlm.nih.gov/pubmed/33257786 http://dx.doi.org/10.1038/s41598-020-77564-3 |
work_keys_str_mv | AT stricklandmichaelr il10basedimmunomodulationinitiatedatbirthextendslifespaninafamilialmousemodelofamyotrophiclateralsclerosis AT ibanezkristenr il10basedimmunomodulationinitiatedatbirthextendslifespaninafamilialmousemodelofamyotrophiclateralsclerosis AT yaroshenkomariya il10basedimmunomodulationinitiatedatbirthextendslifespaninafamilialmousemodelofamyotrophiclateralsclerosis AT diazcarolinaceballos il10basedimmunomodulationinitiatedatbirthextendslifespaninafamilialmousemodelofamyotrophiclateralsclerosis AT borcheltdavidr il10basedimmunomodulationinitiatedatbirthextendslifespaninafamilialmousemodelofamyotrophiclateralsclerosis AT chakrabartyparamita il10basedimmunomodulationinitiatedatbirthextendslifespaninafamilialmousemodelofamyotrophiclateralsclerosis |